How Many Monte Carlo Samples Are Needed for Probabilistic Cost-Effectiveness Analyses?

被引:0
|
作者
Yaesoubi, Reza [1 ,2 ]
机构
[1] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA
[2] Yale Sch Publ Hlth, Publ Hlth Modeling Unit, New Haven, CT USA
关键词
cost-effectiveness analysis; Monte Carlo; probabilistic sensitivity analysis; sample size; CONFIDENCE-INTERVALS; EFFECTIVENESS RATIOS; SENSITIVITY-ANALYSIS; UNCERTAINTY ANALYSIS; MODELS;
D O I
暂无
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objectives: Probabilistic sensitivity analysis (PSA) is conducted to account for the uncertainty in cost and effect of decision options under consideration. PSA involves obtaining a large sample of input parameter values (N) to estimate the expected cost and effect of each alternative in the presence of parameter uncertainty. When the analysis involves using stochastic models (eg, individual-level models), the model is further replicated P times for each sampled parameter set. We study how N and P should be determined. Methods: We show that PSA could be structured such that P can be an arbitrary number (say, P = 1). To determine N , we derive a formula based on Chebyshev's inequality such that the error in estimating the incremental cost-effectiveness ratio (ICER) of alternatives (or equivalently, the willingness-to-pay value at which the optimal decision option changes) is within a desired level of accuracy. We described 2 methods to confirm, visually and quantitatively, that the N informed by this method results in ICER estimates within the specified level of accuracy. Results: When N is arbitrarily selected, the estimated ICERs could be substantially different from the true ICER (even as P increases), which could lead to misleading conclusions. Using a simple resource allocation model, we demonstrate that the proposed approach can minimize the potential for this error. Conclusions: The number of parameter samples in probabilistic cost-effectiveness analyses should not be arbitrarily selected. We describe 3 methods to ensure that enough parameter samples are used in probabilistic cost-effectiveness analyses.
引用
收藏
页码:1553 / 1563
页数:11
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS AND COST-BENEFIT ANALYSES OF VACCINES
    WILLEMS, JS
    SANDERS, CR
    JOURNAL OF INFECTIOUS DISEASES, 1981, 144 (05): : 486 - 493
  • [42] Choosing a Time Horizon in Cost and Cost-effectiveness Analyses
    Basu, Anirban
    Maciejewski, Matthew L.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 321 (11): : 1096 - 1097
  • [43] Cost-effectiveness of targeted screening for abdominal aortic aneurysm -: Monte Carlo-based estimates
    Pentikäinen, TJ
    Sipilä, T
    Rissanen, P
    Soisalon-Soininen, S
    Salo, J
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (01) : 22 - 34
  • [44] Advantages of Monte Carlo Confidence Intervals for Incremental Cost-Effectiveness Ratios: A Comparison of Five Methods
    Dong, Nianbo
    Maynard, Rebecca A.
    Kelcey, Benjamin
    Spybrook, Jessaca
    Li, Wei
    Bowden, A. Brooks
    Pham, Dung
    JOURNAL OF RESEARCH ON EDUCATIONAL EFFECTIVENESS, 2024,
  • [45] USE OF COPULAS FOR CORRELATED SAMPLING OF COST AND UTILITY PARAMETERS DURING PROBABILISTIC SENSITIVITY ANALYSIS FOR COST-EFFECTIVENESS ANALYSES
    Lim, S.
    LoPresti, M.
    Murofushi, T.
    VALUE IN HEALTH, 2023, 26 (12) : S166 - S166
  • [46] Cost-effectiveness Analysis: Why and How
    Campillo-Artero, Carlos
    Ortun, Vicente
    REVISTA ESPANOLA DE CARDIOLOGIA, 2016, 69 (04): : 370 - 373
  • [47] A Practical Guide to Understanding Cost-Effectiveness Analyses
    Greenhawt, Matthew
    Oppenheimer, John
    Codispoti, Christopher D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (12): : 4200 - 4207
  • [48] Cost-effectiveness analyses: A basic overview for dermatologists
    Chen, SC
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2001, 5 (03) : 217 - 222
  • [49] Cost-effectiveness analyses of human papillomavirus vaccination
    Newall, Anthony T.
    Beutels, Philippe
    Wood, James G.
    Edmunds, W. John
    MacIntyre, C. Raina
    LANCET INFECTIOUS DISEASES, 2007, 7 (04): : 289 - 296